MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features"

  • MDS Virtual Congress 2020

    Case Report: Pseudoatetosis as Manifestation of the Vitamin B12 Deficit

    J. Vargas (Bogotá, Colombia)

    Objective: Subacute combined degeneration (DSAC) of the spinal cord is a classic manifestation in the nervous system of vitamin B12 deficiency, clinically characterized by sensory…
  • MDS Virtual Congress 2020

    Motor and non-motor symptoms in Huntington’s disease patients in the Tomsk region, Russia

    M. Nikitina, V. Alifirova, K. Nurzhanova, N. Zhukova (Tomsk, Russian Federation)

    Objective: The aim is to evaluate features of NMS in PwHD of Tomsk region. Background: Patients with Huntington's disease(PwHD) can complain of other non-motor symptoms(NMS)…
  • MDS Virtual Congress 2020

    Clinical and etiological aspects of movement disorders in a low-income country: Case of Mali

    A. Bocoum, S.H Diallo, S. Diallo, A. Koita, Y. Maiga (Bamako, Mali)

    Objective: Describing Clinical and etiological aspects of movement disorders in Mali Background: Movement disorders (MD) correspond to a disturbance in the programming and / or…
  • MDS Virtual Congress 2020

    Development of a time-to-event endpoint for use in premanifest Huntington’s disease (HD) clinical trials

    S. Rossomanno, H. Guthrie, E.J Wild, S.A Schobel, L. Boak, D. Trundell (Basel, Switzerland)

    Objective: To develop and evaluate a time-to-event endpoint to measure disease progression in individuals with premanifest HD. Background: HD is typically diagnosed between the ages…
  • MDS Virtual Congress 2020

    Implementation of an online, interactive curriculum in movement disorders at nine neurology residency programs

    S. Schaefer, Z. London, J. Ferrara, M. McCoyd, C. Cronin, E. Poole Pharr, R. Price, M. Cincotta, H. Rigby, S. Vota, M. Slade, J. Moeller (New Haven, CT, USA)

    Objective: Determine knowledge growth and resident satisfaction with an online curriculum in movement disorders across multiple programs. Background: Exposure to movement disorders in residency is…
  • MDS Virtual Congress 2020

    How Well Does the Composite Unified Huntington’s Disease Rating Scale (cUHDRS) Reflect Disease Progression in Huntington’s disease (HD)?

    C. Snell, H. Smith, J. Castleton, A. Hall, A. Smirnova, B. Wright, P. Gilbert, J. Corey-Bloom (La Jolla, CA, USA)

    Objective: To examine the usefulness of the cUHDRS in reflecting disease progression in a well-characterized group of mild to moderate HD subjects followed at one…
  • MDS Virtual Congress 2020

    Sleep and Polysomnographic Abnormalities in Indian Patients with Huntington’s Disease

    J. Annapureddy, S. D V, N. Kamble, P. Pal, S. Jain, B. Kutty, R. Yadav (Bangalore, India)

    Objective: To study the sleep abnormalities in patients with HD by usingquestionnaire and Video Polysomnography (VPSG) and correlate with the eye movement abnormalities. Background: About 87.8% of the patients report some sleep disturbance…
  • MDS Virtual Congress 2020

    Speech is a sensitive marker in premanifest Huntington’s disease: exploring acoustic, cognitive and fine motor performance

    A. Vogel, J. Chan, Y. Lie, J. Stout (Melbourne, Australia)

    Objective: To explore the utility of objective analysis of speech as a quantifiable clinical biomarker in premanifest HD. Background: The autosomal dominant inheritance of Huntington’s…
  • MDS Virtual Congress 2020

    Huntington’s Disease in Israel – 20 years of follow up from Maccabi Healthcare Services

    Y. Barer, N. Gavrielov, P. Coloma, M. Martinec, I. Korolev, I. Goldshtein (Tel Aviv, Israel)

    Objective: To describe Huntington’s Disease (HD) epidemiology in Israel and depict comorbidities and longitudinal healthcare resources utilization. Background: HD is a rare, inherited neurodegenerative disorder,…
  • MDS Virtual Congress 2020

    Remote and frequent assessment of Huntington’s disease in clinical trials: Strategies for assessing and accounting for the practice effect

    A. Wolfer, F. Lipsmeier, R. Tortelli, F.B Rodrigues, L.M Byrne, C. Simillion, T. Kilchenmann, A. Bamdadian, S.A Schobel, E.J Wild, M. Lindemann (Basel, Switzerland)

    Objective: To assess the impact of task repetition on performance in digital assessments on Huntington’s disease (HD) and establish the number of practice test iterations…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 20
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley